Author Archives: superadmin-pantaipremier

Peraduan Cari Kata Malaysia Prihatin PPP

Peraduan Cari Kata Malaysia Prihatin PPP

Terma & Syarat Peraduan

Peraduan Cari Kata Malaysia Prihatin di media sosial dianjurkan oleh Pantai Premier Pathology dan akan berlangsung dari 25 Ogos 2020 hingga 31 Ogos 2020.

 

Kelayakan

  1. Peraduan ini terbuka kepada semua warga Malaysia yang berumur 18 tahun ke atas kecuali kakitangan Pantai Premier Pathology.
  2. Dengan menyertai Peraduan ini, anda (“Peserta”) bersetuju untuk terikat dengan terma-terma dan syarat-syarat penyertaan dan anda juga bersetuju bahawa semua keputusan pihak Penganjur adalah muktamad dan tidak boleh dipertikaikan.
  3. Peserta bersetuju menyerah kesemua hak ciptanya yang berkenaan kepada pihak Penganjur.

 

Cara Penyertaan

  1. Muat turun atau “screenshot” gambar Cari Kata yang dikongsikan oleh penganjur di dalam media sosial.
  2. Cari dan bulatkan perkataan-perkataan yang telah diberikan dalam senarai petunjuk yang disertakan.
  3. Setelah selesai, muat naik gambar yang lengkap dan pastikan anda menggunakan #PPPMalaysiaPrihatin dan #PantaiPremierPathology dalam kapsyen pos anda.
  4. Pastikan profil anda dalam status “public” untuk proses pemilihan pemenang.
  5. Pemenang-pemenang bertuah akan dipilih dan dinilai mengikut ‘Likes & Shares’ yang tertinggi.

*Platform sosial media yang terlibat: Facebook dan Instagram

 

Pemilihan Pemenang

  1. Seramai 3 pemenang keseluruhan akan dipilih dari laman media social melalui carian dari #PPPMalaysiaPrihatin dan #PantaiPremierPathology. Pemilihan pemenang akan dilakukan oleh pihak Penganjur berdasarkan kepada kriteria-kriteria di bawah:
    1. Jumlah jawapan yang betul.
    2. Jumlah likes yang paling banyak.
    3. Jumlah shares yang paling banyak.
    4. Penilaian juri-juri.
    5. Budi bicara pihak penganjur.

 

Had Liabiliti & Tanggungjawab

  1. Penganjur tidak akan bertanggungjawab untuk sebarang kegagalan, kesilapan dan/atau gangguan yang mungkin akan dihadapi atau ditanggung oleh peserta sebagai akibat langsung atau tidak langsung berikutan daripada sebarang perubahan, lanjutan atau pembatalan peraduan.
  2. Penganjur tidak bertanggungjawab untuk sebarang kegagalan memuatnaik penyertaan ke media sosial yang dihadapi oleh peserta.
  3. Peserta yang layak akan memberi hak penuh kepada Penganjur untuk penggunaan maklumat bagi tujuan promosi di masa hadapan dengan menyertai peraduan ini.
  4. Peserta hendaklah menanggung kerugian penganjur dan/atau penaja daripada dan terhadap semua liability, kos, kerugian atau perbelanjaan yang dialami itu akibat daripada apa-apa pelanggaran Terma & Syarat
  5. Peserta mengakui bahawa penyertaan dalam peraduan adalah pada risiko sendiri. Penganjur dan/atau penaja serah hak tidak akan bertanggungjawab kepada mana-mana peserta berkenaan dengan apa-apa kegagalan untuk memenangi hadiah dalam peraduan, hadiah yang rosak disebabkan kecuaian, tindakan dan/atau peninggalan sendiri atau salah guna hadiah atau apa-apa kerugian lain, ganti rugi, kos, perbelanjaan, tuntutan, liabiliti, kecederaan, kematian dan/atau kemalangan yang dialami oleh peserta semasa peraduan atau yang timbul daripda atau berkaitan dengan peraduan, penyertaan oleh peserta di dalam peraduan dan/atau hadiah yang diterima.

 

Hak Penganjur

  1. Penganjur berhak untuk menggunakan nama dan/atau maklumat peribadi yang diberikan oleh pemenang dan/atau gambar hadiah-hadiahnya sebagai bahan untuk tujuan pengiklanan dan/atau perdagangan dan/atau publisiti semasa penerimaan hadiah dan pemenang tidak berhak untuk membuat tuntutan pemilikan atau mendapat sebarang bentuk pampasan untuk bahan tersebut.
  2. Penganjur berhak untuk membatalkan penyertaan peserta (pada mana-mana peringkat peraduan) atas sebab peserta tidak mematuhi terma-terma yang tertakluk.
  3. Penganjur berhak untuk membatalkan mana-mana penyertaan tanpa menyatakan apa-apa sebab.
  4. Keputusan penganjur adalah muktamad dan sebarang rayuan tidak akan dilayan.
  5. Setiap penyertaan perlu dihantar kepada penganjur semasa atau sebelum tarikh tutup seperti mana yang telah ditetapkan dalam Terma & Syarat. Penyertaan yang dimuat naik selepas waktu tamat tidak akan diterima dan dianggap tidak layak.

 

Terma Penyertaan

  1. Semua peserta sedia maklum dan bersetuju untuk tertakluk di bawah semua Terma & Syarat dan keputusan yang dibuat oleh penganjur.
  2. Penganjur diberikan hak untuk menyiarkan nama dan/atau gambar dan memaparkan sebarang perkara berkaitan pemenang bagi tujuan pengiklanan dan publisiti tanpa memberi notis kepada pemenang.

 

Notis Privasi

  1. Peserta bertanggungjawab bagi memastikan bahawa data peribadi yang diberi adalah tepat, lengkap dan tidak mengelirukan serta memastikan bahawa data peribadi adalah yang terkini.
  2. Peserta bersetuju untuk penganjur dan/atau penaja unttuk mengumpul dan memproses data peribadi peserta.
  3. Semua maklumat peribadi peserta tidak akan dikongsi dengan mana-mana pihak ketiga.

 

Dengan menyertai peraduan ini, peserta dengan ini mengesahkan telah membaca dan bersetuju dengan Terma & Syarat yang ditetapkan.

Tuberculosis (TB)

Tuberculosis (TB)

Tuberculosis (TB) is categorized as one of the top infectious killers worldwide, despite being a preventable and curable disease, due to the devastating health, social and economic impact it poses.1, 2

Each year, 10 million people are getting infected with TB, with 1.5 million deaths recorded in 2018.1, 2 Around 57% of which infected are men, 32% are women and 11% are children who are 15 years old and below. The SouthEast Asia region has been reported to have the highest distribution of TB cases.3

TB is also the leading cause of death in people with HIV, with 251,000 deaths reported and one of the main contributors to antimicrobial resistance with 484,000 individuals who fell ill with drug-resistant TB in 2018.1, 2

Mycobacterium tuberculosis is a bacteria that is responsible for TB infection by affecting the lungs.2, 4 TB is spread through airborne transmission when a person with the disease coughs, sneezes or spits and another individual needs to only inhale a few germs from the infected droplets to become infected.4

Most TB cases are reported to progress from latent TB infection (LTBI) rather than local transmission, especially in those whose immune systems are weakened. Hence, the transmission of the infectious TB can be prevented through prompt case finding and treatment of LTBI as a crucial strategy to achieve the elimination of TB.4, 5, 6

 

 

Reference:

  1. World Tuberculosis Day 2020. (n.d.). World Health Organization. Retrieved July 22, 2020, from https://www.who.int/campaigns/world-tb-day/world-tb-day-2020
  2. Tuberculosis. (n.d.). World Health Organization. Retrieved July 22, 2020, from https://www.who.int/health-topics/tuberculosis#tab=tab_1
  3. World Health Organization. (2019). TB Report (1.1) [Mobile App]. Play Store. https://apps.apple.com/my/app/tb-report/id1483112411
  4. Latent TB Infection and TB Disease. (2016). Centers for Disease Control and Prevention. https://www.cdc.gov/tb/topic/basics/tbinfectiondisease.htm
  5. Lönnroth, K., Migliori, G. B., Abubakar, I., D’Ambrosio, L., De Vries, G., Diel, R., … & Ochoa, E. R. G. (2015). Towards tuberculosis elimination: an action framework for low-incidence countries. European Respiratory Journal, 45(4), 928-952.
  6. Dobler, C. C., Martin, A., & Marks, G. B. (2015). Benefit of treatment of latent tuberculosis infection in individual patients. European Respiratory Journal, 46(5), 1397-1406.

Webinar TB – Lurking in the shadows of COVID-19

This event is co-organised by Pantai Premier Pathology and QIAGEN.

According to “Stop TB Partnership”, Tuberculosis (TB) remains the world’s biggest infectious disease killer, claiming around 1.5 million people globally every year (1). In Malaysia alone, more than 25,000 new cases of TB were reported in 2018 (2).
A global reduction of 25% in TB detection for 3 months due to the disruption of TB services from the COVID-19 pandemic could result in a 13% increase of TB deaths (3). As a result, we could see an additional 1.4 million TB deaths between 2020 and 2025 (3).
Join us in this live webinar as we discuss how we can best meet the UN’s call to maintain critical TB testing and treatment services during the COVID-19 pandemic response. Register now.
Event Details
Date:

August 18, 2020

Time:

1:00 – 2:00 p.m.

CPD points are available for attendees

Speakers

 

Dual burden of TB and COVID-19
Dr. Mohd Ihsani Mahmood
TB Leprosy Sector, Disease Control Division
Ministry of Health

 

Next chapter in preventing TB – LTBI
Mr. Calvin Sum
Sales Development Manager, SEA
QIAGEN

Hepatitis C: Know the facts

Hepatitis C: Know the facts

Hepatitis is a group of infectious diseases that affects 325 million people worldwide. Hepatitis C alone has been estimated to infect around 71 million people globally with either acute or chronic infection. Most individuals that have chronic infection will develop cirrhosis or liver cancer.2, 3, 5, 6 In 2016, WHO estimated that approximately 399,000 people have died from hepatitis C, mostly from cirrhosis and primary liver cancer (hepatocellular carcinoma).1

 

What is Hepatitis C?

Hepatitis C infection occurs due to the inflammation of the liver caused by hepatitis C virus.3

 

What are the symptoms of Hepatitis C?

Individuals infected with hepatitis C are usually unaware that they are infected as it occurs with minimal to no clinical symptoms and are non-specific in most cases.7

When symptoms are present, they include extreme fatigue, jaundice, vomiting, dark urine, pale-coloured stool, loss of appetite and abdominal pain.1

 

What causes Hepatitis C?

Hepatitis holds a great concern due to the burden of death it causes and its potential of causing an outbreak and epidemic spread.

Hepatitis C is mainly transmitted through parenteral contact with contaminated blood such as from infected mother to child at birth, through sharing medical equipment (i.e. needle and syringe) and personal items (i.e. razor and toothbrush) and less frequently through unprotected blood-to-blood sexual contact with an infected person.1, 3, 5, 6, 7, 8

 

Who gets Hepatitis C?

Individuals at risk of hepatitis C are those in the healthcare profession, having multiple sexual partners and intravenous drug abusers.1, 8

Most cases are due to unknown origin which means an individual does not need to be included in a high-risk group in order to be infected with a hepatitis virus.

 

How is Hepatitis C diagnosed?

Since hepatitis C infection is usually asymptomatic, very few individuals are diagnosed and may have developed chronic hepatitis C infection which can lead to serious health problems including secondary to serious liver damage. Hence, it is important for an individual to do early screening to prevent the advancement of the disease.1, 3

Hepatitis C infection is diagnosed by testing for anti-hepatitis C virus antibodies with a serological test which identifies individuals that have been infected with the virus.

After an individual has been diagnosed with hepatitis C virus infection, an assessment of the degree of liver damage (fibrosis or cirrhosis) will be made through liver biopsy.1

The degree of liver damage is done to be used as a guide for making decisions for the management and treatment of the disease.1

 

In conclusion, hepatitis C infection is preventable, treatable and curable. Most individuals affected either lack prevention, testing or treatment.1 Hence, early screening and detection is an important step to prevent the progression to chronic infection (cirrhosis or liver cancer) and to reduce liver-related morbidity and mortality.6

 

Source:

  1. Hepatitis C. (2017, July 9). World Health Organization. https://www.who.int/news-room/fact-sheets/detail/hepatitis-c
  2. World Hepatitis Day 2019. (n.d.-a). World Health Organization. Retrieved July 24, 2020, from https://www.who.int/campaigns/world-hepatitis-day/2019
  3. What is Viral Hepatitis? (n.d.). Centers for Disease Control and Prevention. Retrieved July 24, 2020, from https://www.cdc.gov/hepatitis/abc/index.htm
  4. World Hepatitis Day — July 28th. (n.d.). Centers for Disease Control and Prevention. Retrieved July 24, 2020, from https://www.cdc.gov/hepatitis/awareness/worldhepday.htm
  5. (İskender, G., Mert, D., Çeken, S., Bahçecitapar, M., Yenigün, A., & Ertek, M. (2020). Hepatitis C screening and referral for further investigation and treatment in a tertiary care hospital. The Journal of Infection in Developing Countries, 14(06), 642-646.
  6. Guss, D., Sherigar, J., Rosen, P., & Mohanty, S. R. (2018). Diagnosis and management of hepatitis C infection in primary care settings. Journal of general internal medicine, 33(4), 551-557.
  7. Mohd Suan, M. A., Said, S. M., Lim, P. Y., Azman, A. Z. F., & Abu Hassan, M. R. (2019). Risk factors for hepatitis C infection among adult patients in Kedah state, Malaysia: A case–control study. PloS one, 14(10), e0224459.
  8. Ghany, M. G., Strader, D. B., Thomas, D. L., & Seeff, L. B. (2009). Diagnosis, management, and treatment of hepatitis C: an update. Hepatology, 49(4), 1335-1374.

COVID-19 & Non-Communicable Diseases (NCDs)

COVID-19 & Non-Communicable Diseases (NCDs)

NCD (Non Communicable Disease)

Noncommunicable diseases (NCDs), also known as chronic diseases, tend to be of long duration and are the result of a combination of genetic, physiological, environmental and behaviours factors.

Risk Factors

  • Smoking
  • physical inactivity
  • unhealthy diet
  • harmful use of alcohol
  • overweight/obesity

Who is at Risk?

People of all age groups, regions and countries are affected by NCDs. These conditions are often associated with older age groups, but evidence shows that 15 million of all deaths attributed to NCDs occur between the ages of 30 and 69 years.

NCD Statistics

  • Noncommunicable diseases (NCDs) kill 41 million people each year, equivalent to 71% of all deaths globally.
  • Cardiovascular diseases account for most NCD deaths, or 17.9 million people annually.
  • According to 2015 National Health and Morbidity Survey (NHMS), about 2/3 of Malaysians have at least 1 of 3 NCDs.

Did you know?

! People with pre-existing non-communicable diseases (NCDs) appear to be more vulnerable to becoming severely ill with the COVID-19 virus.

! Risk of becoming severely ill increases with age

 

Tests offered for NCDs by Pantai Premier Pathology

NCD3 Profile, stands for Non-Communicable Disease (Diabetes, High Cholesterol & CV diseases) includes 4 main screenings:

Lipid Screening:

  • Total Cholesterol
  • HDL-Cholesterol
  • LDL- Cholesterol
  • Triglycerides
  • Cholesterol/HDL Ratio
Diabetic Screening:

  • Fasting/Random blood glucose
  • Glycated Haemoglobin (HbA1C)
Cardiac Screening:

  • Risk Stratification Cardiac Troponin I (RSTROPI)

Obesity Screening:

  • Body Mass Index (BMI)

 

Reference: 

1) World Health Organization. (2018, June 1). A report on noncommunicable diseases. Retrieved from https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases

2) Institute for Public Health (IPH) 2015. National Health and Morbidity Survey 2015 (NHMS 2015). Vol. II: Non-Communicable Diseases, Risk Factors & Other Health Problems; 2015.

3) World Health Organization. (2020). COVID-19 and NCDs. Information Note. Retrieved from https://www.who.int/emergencies/diseases/novel-coronavirus-2019